Inclusion Criteria:

• 1. Age ≥ 18 female.
• 2. Able to read and write in English.
• 3. History of any stage of breast and/or gynecological cancer.
• 4. Completed primary treatment (chemotherapy, radiation and/or surgery) ≥ 3 months and ≤ 5 years prior to registration.
• 5. May use maintenance therapy and concurrent adjuvant endocrine therapy or human epidermal growth factor receptor 2 negative (HER2-) targeted therapy while on study.
• 6. Have a stable partner, defined as anyone with whom the woman has had an intimate relationship for at least 3 months prior to her cancer diagnosis.
• 7. Responds yes to the question "Has there been a change in communication and/or intimacy with your partner since your cancer diagnosis?"
• 8. Both partner and woman patient must agree to participate in the study and sign informed consent to the study.
• 9. Psychiatric medications such as antidepressants and benzodiazepines are allowed if a person has been on them for 30 days prior to registration, and dose or treatment is not expected to change.

Exclusion Criteria:

• 1. Past history of sexual abuse.
• 2. Uncontrolled psychiatric disorder such as major depressive disorder, bipolar disorder, obsessive compulsive disorder, or schizophrenia (Defined per medical history and/or patient self-report).
• 3. Currently enrolled in another study that addresses sexual health (enrollment in other clinical trials will be allowed).